biotech investing BriaCell Receives Positive Recommendation from Data Safety Monitoring Board for Phase 3 Study in Metastatic Breast Cancer
biotech investing BriaCell Expands Pipeline to Include an Ovarian Cancer Immunotherapy Candidate, Bria-OVA+
biotech investing BriaCell Completes Manufacturing of Clinical Supplies of Bria-PROS+ for Prostate Cancer
biotech investing BriaCell Adds Penn Medicine's Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study
biotech investing BriaCell Adds NYU Langone Health's Perlmutter Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study
biotech investing BriaCell Receives FDA Clearance to Initiate Bria-BRES+ Clinical Study in Breast Cancer
biotech investing BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+ in Preclinical Cancer Models
